Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Athersys Inc.

Athersys Inc.

Athersys Inc.

Cleveland, Ohio

Technology: RAGE random gene expression technology and synthetic human microchromosomes

Disease focus:

Read the full 203 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE